Literature DB >> 6376323

Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.

H C Hsu, W Y Chen, G J Lin, L Chen, S L Kao, C C Huang, C Y Lin.   

Abstract

Forty-one out of 408 cases (or 10%) of primary glomerular disease had diffuse fine granular to arc-like short linear mesangial deposits of IgM by direct immunofluorescence. The IgM deposition was accompanied by C1q and/or C4 in the same locality in 29 cases, by C3 in 10, and by trace amounts of IgA in 6. Properdin-factor B was not detected. Fine granular electron dense deposits of low density were detected in the mesangium in all 41 cases by electron microscopy, usually as a discrete granular or arc-like pattern beneath the mesangial glomerular basement membrane and correlated well with the immunofluorescence findings. An immune complex disease with complement activation via the classical pathway is suggested. The ages of the patients varied from 2 to 58 years (average 23.8 years). A male predominance of 2.2:1 was identified. Serum IgM level was elevated in 46.7% of the cases. The majority (87.8%) of the cases manifested a nephrotic syndrome or relapse at time of biopsy, and the remaining cases experienced persistent or intermittent proteinuria. Among the 36 nephrotic patients, 22 cases (61.1%) demonstrated complete remission with steroid therapy, 9 cases (25%) were resistant, and 5 cases (13.9%) had partial remission. Complete and partial remissions were later achieved with cytotoxic drugs or methylprednisolone pulse therapy in 3 and 4 cases respectively in the steroid resistant patients. Frequent relapses occurred during the course in 22 out of 32 cases (68.8%) who had experienced complete or partial remission. Follow-up study after biopsy demonstrated that sustained complete remission was achieved with prednisolone with or without cytotoxic drugs and pulse therapy in only 14 (42.4%) of the 33 nephrotic cases who had been followed up for longer than 6 months, and six of them had had previous relapses. Pathologically, 56.1% of the patients showed mild to moderate increase in mesangial matrix and cellularity. Focal and segmental sclerosis was demonstrated in four cases (9.8%). However, minimal glomerular change was also common (34.1%). The patients with minimal change seemed to have a higher complete remission rate than patients with more evident glomerular alterations, although the difference was not statistically significant. This clinical and immunopathological study suggests that mesangial IgM nephropathy is an important disease in Taiwan, with a variable response to treatment and frequent relapses.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376323     DOI: 10.1111/j.1365-2559.1984.tb02355.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

1.  IgM nephropathy; time to act.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2014-01-01

2.  In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy.

Authors:  C Y Lin; C H Chen; P P Lee
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

3.  Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Authors:  Sarah J Swartz; Karen W Eldin; M John Hicks; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2009-02-14       Impact factor: 3.714

4.  Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.

Authors:  Yi-Miao Zhang; Qiu-Hua Gu; Jing Huang; Zhen Qu; Xin Wang; Li-Qiang Meng; Fang Wang; Gang Liu; Zhao Cui; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

5.  Clinicopathological features and prognosis of Chinese children with idiopathic nephrotic syndrome between different age groups.

Authors:  Jei-Wen Chang; Hsin-Lin Tsai; Hsin-Hui Wang; Ling-Yu Yang
Journal:  Eur J Pediatr       Date:  2008-12-20       Impact factor: 3.183

6.  Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular "immune deposits".

Authors:  R Habib; E Girardin; M F Gagnadoux; N Hinglais; M Levy; M Broyer
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

7.  IgM contributes to glomerular injury in FSGS.

Authors:  Derek Strassheim; Brandon Renner; Sarah Panzer; Richard Fuquay; Liudmila Kulik; Danica Ljubanović; V Michael Holers; Joshua M Thurman
Journal:  J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 10.121

8.  Circulating heavy IgM in IgM nephropathy.

Authors:  S O Disciullo; J G Abuelo; K Moalli; J C Pezzullo
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

Review 9.  IgM nephropathy; can we still ignore it.

Authors:  Aruna Vanikar
Journal:  J Nephropathol       Date:  2013-04-01

Review 10.  IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

Authors:  R Brugnano; R Del Sordo; C Covarelli; E Gnappi; S Pasquali
Journal:  J Nephrol       Date:  2016-02-03       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.